Related references
Note: Only part of the references are listed.In Vitro Activity of Minocycline against US Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018
Robert K. Flamm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model
Ziad Tarazi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Nonlinear Protein Binding: Not What You Think
Amelia N. Deitchman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
1387. Phase I Study to Evaluate the Safety and Pharmacokinetics (PK) of Single and Multiple Ascending Doses (SAD/MAD) of Intravenous (IV) Minocycline in Healthy Adult Subjects
Oliver A Cornely et al.
Open Forum Infectious Diseases (2018)
The complexity of minocycline serum protein binding
Jian Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains
Agnieszka Chmielarczyk et al.
MICROBIAL DRUG RESISTANCE (2016)
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
Dana R. Bowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii
H. Adibhesami et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Minocycline: An Old Drug for a New Bug: Multidrug-Resistant Acinetobacter baumannii
Debra A. Goff et al.
CLINICAL INFECTIOUS DISEASES (2014)
Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options
Mariana Castanheira et al.
CLINICAL INFECTIOUS DISEASES (2014)
Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections
Debra A. Goff et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
David J. Ritchie et al.
CLINICAL INFECTIOUS DISEASES (2014)
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
Steven Casha et al.
BRAIN (2012)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Minocycline Development for Acute Ischemic Stroke
Susan C. Fagan et al.
TRANSLATIONAL STROKE RESEARCH (2011)
Minocycline to Improve Neurologic Outcome in Stroke (MINOS) A Dose-Finding Study
Susan C. Fagan et al.
STROKE (2010)
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study
Simon Finfer et al.
BRITISH MEDICAL JOURNAL (2006)
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
PHARMACEUTICAL RESEARCH (2005)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Penetration of minocycline hydrochloride into lung tissue and sputum
A Watanabe et al.
CHEMOTHERAPY (2001)
Share Paper
